• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Dental procedures in patients taking antithrombotics
Patients taking medications for thrombus or clot formation disorders are often seen in the dental office. These individuals are at a higher risk for bleeding while they are taking these medications, yet their risk for stroke, acute coronary syndrome (ACS), and venous thromboembolism (VTE) increases if the medications are discontinued. Dental practitioners have followed various recommendations for the use of these agents, but newer agents have come on the market and recommendations change. Antithrombotics fall into the categories of anticoagulant, antiplatelet, or fibrinolytic agents.
Source: Dental Abstracts - November 1, 2017 Category: Dentistry Tags: Hands On Source Type: research

Management of phenytoin-induced gingival enlargement in a patient with antiphospholipid antibody syndrome: A rare case report
Shilpa Sarvesh Urolagin, Deepthi Swaroop, Charu Agrawal, Pathik Dholakia, Menaka Basavanneppa KaralwadJournal of Indian Society of Periodontology 2016 20(5):561-564 Antiphospholipid antibody (APLA) syndrome is a noninflammatory autoimmune disease, with innumerable clinical manifestations ranging from recurrent thrombosis and pregnancy morbidity to valvular lesions, transverse myelitis, thrombocytopenia, and hemolytic anemia. APLAs in antiphospholipid syndrome (APS) are well-known risk factors for cerebrovascular accidents. Stroke is the most common manifestation of APS in the central nervous system. Gingival enlargement i...
Source: Journal of Indian Society of Periodontology - October 17, 2017 Category: Dentistry Authors: Shilpa Sarvesh Urolagin Deepthi Swaroop Charu Agrawal Pathik Dholakia Menaka Basavanneppa Karalwad Source Type: research

Novel oral anticoagulants
Anticoagulants are often prescribed for patients who have thromboembolic disease or are at risk for thromboembolism or embolic stroke. These agents work by changing the physiologic procoagulant and anticoagulant pathways, either preventing the formation of a clot or slowing progression of an existing clot. The traditional oral anticoagulant is warfarin, which is highly effective in treating thromboembolic disease when carefully managed, but it has the drawbacks of needing frequent monitoring of the patient ’s international normalized ratio (INR) and being associated with patient noncompliance.
Source: Dental Abstracts - December 23, 2016 Category: Dentistry Tags: Hands On Source Type: research